Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
11 Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2025
12 Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters Department of Medical Oncology Israa Mostafa Kamal Mohammed 2025
13 Predictive Factors for Site of Local and Systemic Recurrence in Breast Cancer Patients Department of Medical Oncology Dr. Ahmed Mubarak Hefni Ismail 2025
14 The prognostic impact of PBRM1 immunohistochemical expression and its association with CD3+ and CD8+ immune cells in patients with renal cell carcinoma: A retrospective study Department of Pathology Amira Emad Mohamed Elwy 2025
15 The prognostic impact of PBRM1 immunohistochemical expression and its association with CD3+ and CD8+ immune cells in patients with renal cell carcinoma: A retrospective study Department of Pathology Dr. Shimaa Hassan Shabaan Hassan 2025
16 Predictive Factors for Site of Local and Systemic Recurrence in Breast Cancer Patients Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2025
17 Safety and Efficacy of Outpatient Management Strategy for Low-Risk Febrile Neutropenia in Pediatric Oncology: A Tertiary Care Experience in Egypt Department of Pediatric Oncology Dr. Khaled Fathy Riad Osman 2025
18 Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters Department of Medical Oncology Dr. Ahmed Mubarak Hefni Ismail 2025
19 Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2025
20 The prognostic impact of PBRM1 immunohistochemical expression and its association with CD3+ and CD8+ immune cells in patients with renal cell carcinoma: A retrospective study Department of Pathology Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2025